These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971 [TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326 [TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab induction in deceased donor kidney transplantation. Huang E; Cho YW; Hayashi R; Bunnapradist S Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833 [TBL] [Abstract][Full Text] [Related]
9. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation. Umber A; Killackey M; Paramesh A; Liu Y; Qin H; Atiq M; Lee B; Alper AB; Simon E; Buell J; Zhang R J Nephrol; 2017 Apr; 30(2):289-295. PubMed ID: 27062485 [TBL] [Abstract][Full Text] [Related]
10. Diffuse alveolar hemorrhage and acute respiratory distress syndrome during treatment of rheumatoid arthritis with etanercept. Khaja M; Menon L; Niazi M; Fuentes GD J Bronchology Interv Pulmonol; 2012 Jul; 19(3):228-31. PubMed ID: 23207468 [TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report. Alnahdi MA; Aljarba SI; Al Malik YM Mult Scler Relat Disord; 2020 Jun; 41():102141. PubMed ID: 32446212 [TBL] [Abstract][Full Text] [Related]
13. Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case. Ikeda S; Sekine A; Kato T; Yoshida M; Ogata R; Baba T; Nagahama K; Okudela K; Ogura T Jpn J Clin Oncol; 2014 May; 44(5):497-500. PubMed ID: 24683198 [TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience. Supe-Markovina K; Melquist JJ; Connolly D; DiCarlo HN; Waltzer WC; Fine RN; Darras FS Pediatr Transplant; 2014 Jun; 18(4):363-8. PubMed ID: 24712738 [TBL] [Abstract][Full Text] [Related]